Observational × Head and Neck Neoplasms × Thoracic × Clear all SHERLOCK
Recruiting
7,000 enrolled
FL-261 Imaging for Cancer Diagnosis and Staging
Recruiting
12 enrolled
DP-04
Recruiting
100 enrolled
COPD Care Pathway Among Patients With Cancer
Active not recruiting
101 enrolled
ALTAK
Completed
385 enrolled
MOMENTUM
Recruiting
8,000 enrolled
QVA-Mod
Not yet recruiting
180 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Recruiting
1,250 enrolled
CAMPERR
Recruiting
7,000 enrolled
SCORE
Recruiting
9,600 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
LIBERATE
Recruiting
2,500 enrolled
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
Active not recruiting
1,150 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
SMALLHAN
Completed
165 enrolled
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Recruiting
700 enrolled
OvAR-Y
Recruiting
10 enrolled
DART
Not yet recruiting
80 enrolled
DELFI-L101
Completed
2,992 enrolled
DESCENT-1
Enrolling by invitation
400 enrolled
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Recruiting
200 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
A Multicenter Cancer Biospecimen Collection Study
Recruiting
1,650 enrolled
99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
Recruiting
20 enrolled
PREFER
Completed
1,429 enrolled
MOM
Completed
40 enrolled
FUTURE
Not yet recruiting
640 enrolled
MOHCCN-O
Recruiting
500 enrolled
Improving Evidence-Based Care for Cancer Patients
Completed
128 enrolled
ROOT
Completed
167 enrolled
OCTANE
Recruiting
10,000 enrolled
SkinHealth
Recruiting
420 enrolled
Radiogenomics in Aerodigestive Tract Cancers
Completed
139 enrolled
POSITive
Unknown
265 enrolled
MORRIS
Completed
118 enrolled
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Terminated
20 enrolled
Developing Artificial Intelligence-based Algorism to Predict Side Effects and Symptoms From Chemotherapy
Recruiting
500 enrolled
G-DEFINER
Completed
247 enrolled
This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
Terminated
22 enrolled
Oral Glutamine and Thoracic/Upper Aerodigestive Tumors Radiation Toxicity
Completed
72 enrolled
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Unknown
279 enrolled
PIONEER
Unknown
1,000 enrolled
Study to Evaluate the Safety of Nanoxel M Inj.
Unknown
1,498 enrolled
N1
Terminated
23 enrolled
Measuring the Effect of Radiation Therapy on Patient Activity Levels
Terminated
32 enrolled
Predicting Tolerance to Radiation Therapy in Older Adults With Cancer
Completed
50 enrolled
Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871
Completed
69 enrolled